Recent developments in diagnosis and classification of MDS

Pathology Clinical Conference

Wednesday, November 13, 2019 at 12:00 PM


Grand Round starts in:

Pathology level 2 conference room - Stony Brook, NY
November 13th, 2019
1.00 AMA PRA Category 1 Credit Hours

Description

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphological dysplastic changes in one or more of the major hematopoietic cell lines. MDS can present with varying degrees of single or multiple cytopenias including neutropenia, anemia and thrombocytopenia. In this presentation I will talk about diagnosis and classification of MDS and MDS/MPN with emphasis on recent updates in the WHO classification system.

Dates and Times

Start: 11/13/2019 12:00 PM
End: 11/13/2019 1:00 PM

Objectives

Objectives:

To introduce the audience to the features of hematopoietic dysplasia.

To introduce the audience to the different types of MDS and MDS/MPN

To update the audience on the recent changes in WHO classification

Speakers

  • Dr. Roman Gonta
    • Recent developments in diagnosis and classification of MDS

Location

Pathology level 2 conference room
100 Nicolls rd
university hospital room 749
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222